Moderna, Inc. (MRNA) /

The debt of Moderna, Inc. over the past 10 years

Chart Moderna, Inc.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →

At the end of fiscal 2025, the latest fiscal year on file, Moderna, Inc. had liquid cash of $5.8B and total debt of $590M: net cash of $5.21B. It had more liquid cash than debt at all 9 year-ends shown. Total debt was highest at the end of fiscal 2025 ($590M) and lowest at the end of fiscal 2017 ($0).

Year by year

Fiscal yearLiquid cashTotal debt*Net cash*
2025ended Dec 31, 2025$5.8B*$590M$5.21B
2024ended Dec 31, 2024$7.03B*$0$7.03B
2023ended Dec 31, 2023$8.6B*$0$8.6B
2022ended Dec 31, 2022$9.9B*$0$9.9B
2021ended Dec 31, 2021$10.73B*$0$10.73B
2020ended Dec 31, 2020$4.61B*$0$4.61B
2019ended Dec 31, 2019$1.1B*$0$1.1B
2018ended Dec 31, 2018$1.52B*$0$1.52B
2017ended Dec 31, 2017$756.03M*$0$756.03M
2016ended Dec 31, 2016———

Fiscal years as Moderna, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on Moderna, Inc.

Companies of a similar size

Not investment advice. This page shows what Moderna, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.